May 14, 2026
Submission Automation Is The Wedge
New Intel: Astraea’s public product surface centers on FDA-ready biometrics automation, especially SDTM, ADaM, TFLs, and validation. If it works, the budget target is CRO statistical programming spend, putting ICON and Saama in the exposed zone.